Evonik Industries offers a full range of custom API manufacturing services as well as oral and parenteral formulation development expertise. Our global manufacturing footprint and technical expertise provides unique flexibility and problem solving capabilities to meet your most demanding project’s requirements.
As a
read moreglobal leader in HPAPI manufacturing, we can seamlessly take your project from lab scale through to large commercial multi-ton quantities. Our global development and manufacturing network provides increased flexibility to meet your demanding requirements. At our facility in Lafayette, IN, which has been producing commercial quantities of HPAPIs for two decades, we operate with OELs <0.1 µg/m3. Evonik has experienced people with the right expertise, the right equipment and the right motivation to see your high potency projects from clinical stages through commercialization.
Our offering also includes the manufacture of non-exclusive intermediates and APIs such as L-tert-leucine based building blocks, Lisinopril, Lorazepam and Nifedipin. We also offer amino acids, amino acid derivatives, and small chain peptides for parenteral or oral nutrition, or as building blocks for synthesis.
For your formulation needs, Evonik produces functional excipients for modified oral delivery (EUDRAGIT®) and bioresorbable polymers for extended release parenteral formulations or medical devices (Resomer®). We offer formulation development services for both oral and injectable forms. Evonik has expertise in solubility and bioavailability enhancement of oral formulations utilizing spray drying, hot melt extrusion and other proprietary technologies. We also have expertise in injectable extended release formulations including microsphere, gel and implants.
Custom manufacturing services for oral drug products from preclinical to clinical phases as well as parenteral drug manufacturing from clinical through drug commercialization are also offered.
